Scalper1 News
Shares of spinal-products company NuVasive (NUVA) popped to a nearly four-year high on the stock market today, a day after the firm beat analysts’ Q4 profit expectations. In January, NuVasive had already given a preliminary sales number of $189 million, but the final number turned out to be $191 million, up 15% from the year-earlier quarter. Profit, which was not previously reported, rose 9% to 37 cents a share, beating analysts’ consensus by 5 Scalper1 News
Scalper1 News